top of page

Chung-Ang University study looks at cardiovascular risks in COVID-19 survivors

Chung-Ang University study looks at cardiovascular risks in COVID-19 survivors

The emergence of COVID-19 pandemic caused as a result of severe acute respiratory syndrome-coronavirus marked a global health crisis with over 770 million cases of infection and 6 million deaths by September 6, 2023. Around 6.2% of the recovered individuals, however, face lingering symptoms such as fatigue or respiratory problems. Although interstitial pneumonitis and severe acute respiratory distress syndrome are the main effects of COVID-19 on the lungs, the virus also affects other organs, especially the cardiovascular system. Despite this, previous studies assessing cardiovascular outcomes in post-acute COVID-19 patients were limited by insufficiently adjusting for preexisting cardiovascular conditions among hospitalized individuals.

To overcome this limitation, a team of scientists led by Dr Won-Young Kim, along with Professor Sun–Young Jung from Chung-Ang University, Korea, conducted a nationwide population-based cohort study. They aimed to explore the risk of cardiovascular outcomes among individuals who survived acute COVID-19 hospitalization without preexisting cardiovascular conditions. The results of their study were published online on 20 October 2023, in BMC Medicine

The researchers used hospitalized patients with non-COVID-19 pneumonia as a historical comparison control group. Explaining the rationale for this study design further, Dr Kim says, "Previous studies that assessed the risk of cardiovascular outcomes after COVID-19 selected general hospital admission as controls, neglecting the potential cardiovascular risks following non-COVID-19 pneumonia hospitalization. In addition, the demographic composition of previous studies (based on mostly White and older male populations) may limit the generalizability of the results."

The study utilized the Korean National Health Insurance Service database, encompassing nearly 97% of Korea's population. The database offered comprehensive details on demographics, diagnoses, treatments, and outcomes, linked to confirmed cases and vaccination information. The research focused on two groups—the first comprised 132,784 adults hospitalized for COVID-19 between October 2020 and September 2021, while the second consisted of a historical control group of 31,173 adults hospitalized for non-COVID pneumonia between January and December 2019.

The primary outcome measured was major adverse cardiovascular events, with secondary outcomes encompassing specific cardiovascular conditions and mortality. Various other subgroup and sensitivity analyses were conducted along with statistical analyses.

Interestingly, the researchers found no increased incidence of post-acute cardiovascular issues in those adults hospitalized with COVID-19 compared to those hospitalized for non-COVID-19 pneumonia. COVID-19 survivors exhibited lower risks of all-cause mortality, congestive heart failure, and cardiac arrest, but faced notably higher risks of acute myocarditis and deep vein thrombosis. Further, younger COVID-19 patients, especially those without cardiovascular risk factors, showed elevated risks of cardiovascular complications, implying that COVID-19 may be an independent risk factor in this subgroup. Sensitivity analyses with preexisting cardiovascular disease and subgroup assessments confirmed these trends, emphasizing the impact of COVID-19 on cardiovascular outcomes. Additionally, non-vaccinated COVID-19 patients exhibited increased risks of various adverse cardiovascular events.

Discussing the results further, Dr Kim remarks, "Our results suggest that COVID-19 vaccination may prevent cardiovascular outcomes. This supports vaccination, especially for patients with preexisting cardiovascular disease."

This study is the first to compare the risk of cardiovascular outcomes between COVID-19 and non-COVID-19 pneumonia among the East Asian population. While prior Western studies suggested elevated cardiovascular risks post-COVID-19, this research has revealed low risks in Korean patients following acute COVID-19 hospitalizations. Going ahead, these findings can offer valuable insights for healthcare practitioners and policymakers to devise effective strategies for the long-term care of COVID-19 patients.

Reference: Title of original paper: Cardiovascular outcomes between COVID-19 and non-COVID-19 pneumonia: a nationwide cohort study

Reach out to us at PR Desk 

Read more on our Partner sites: Dais World | Growth Reports Business

Get rewarded for your reading habits on the Dais World app!


The Progress Catalyst


Throughout history, there have been individuals who have made a profound impact on the world. These individuals have pushed the boundaries of what is possible, and have made the world a better place for all. We will keep exploring the lives and work of these progress catalysts, and show how their contributions have shaped the world we live in today.


The Progress Catalyst is a celebration of these individuals. It is a tribute to their courage, their vision, and their determination. It is a reminder that we all have the power to make a difference in the world.

Posts Archive


bottom of page